Yellow Fever–Associated Viscerotropic Disease in Barcelona, Spain
Open Access
- 1 May 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 15 (3), 202-205
- https://doi.org/10.1111/j.1708-8305.2008.00209.x
Abstract
Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine–associated viscerotropic disease (YEL‐AVD) have been described. We report a new case of YEL‐AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.Keywords
This publication has 16 references indexed in Scilit:
- Immune Response during Adverse Events after 17D‐Derived Yellow Fever Vaccination in EuropeThe Journal of Infectious Diseases, 2008
- A sensitive one-step real-time RT-PCR method for detecting Grapevine leafroll-associated virus 2 variants in grapevineJournal of Virological Methods, 2007
- Yellow fever vaccine-associated viscerotropic disease and death in SpainJournal of Clinical Virology, 2006
- Characterization of a viscerotropic yellow fever vaccine variant from a patient in BrazilVaccine, 2006
- Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse eventsVaccine, 2005
- History of thymoma and yellow fever vaccinationThe Lancet, 2004
- Genetic Divergence and Dispersal of Yellow Fever Virus, BrazilEmerging Infectious Diseases, 2004
- Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever VaccinationEmerging Infectious Diseases, 2001
- Yellow fever: an updateThe Lancet Infectious Diseases, 2001
- Yellow Fever VaccinationThe American Journal of the Medical Sciences, 1956